RIL, a protein intricately involved in cytoskeletal organization and cell adhesion, is functionally modulated by a diverse array of chemical activators. Forskolin, by elevating intracellular cAMP, activates PKA, which in turn can phosphorylate substrates critical for cytoskeletal dynamics, thereby enhancing RIL's role in stabilizing actin structures. Similarly, PMA, through its activation of PKC, influences pathways governing actin dynamics, indirectly augmenting RIL's functionality in cellular adhesion. The PI3K inhibitors LY294002 and Wortmannin, by modulating PI3K pathways, also contribute to the reorganization of cytoskeletal elements where RIL is active, indirectly bolstering its functional role. Further, the MEK1/2 inhibitor U0126 and the p38 MAPK inhibitor SB203580 redirect signaling towards RIL-involved pathways, particularly those related to cell adhesion, thus enhancing RIL's activity.
In addition to these kinase modulators, other compounds play crucial roles in influencing RIL's activity through distinct mechanisms. Rapamycin, by inhibiting mTOR, indirectly affects pathways integral to cytoskeletal dynamics and cell adhesion, thus potentially enhancing RIL's involvement in these processes. The calcium ionophore A23187 elevates intracellular calcium levels, thus activating signaling pathways critical for cytoskeletal rearrangement where RIL is functionally significant. Staurosporine, despite its broad kinase inhibition profile, selectively shifts cellular signaling in favor of pathways involving RIL. Genistein, as a tyrosine kinase inhibitor, modulates signaling intersections relevant to RIL, particularly in cytoskeletal organization. Sphingosine-1-phosphate, through its role in cell migration signaling, and EGCG, by influencing cell adhesion pathways, further contribute to the enhancement of RIL's functional activity. Collectively, these RIL activators, through their targeted effects on diverse cellular signaling pathways, facilitate the enhancement of RIL's role in cytoskeletal dynamics and cell adhesion without necessitating direct activation or upregulation of its expression.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Increases intracellular cAMP levels, activating protein kinase A (PKA). PKA phosphorylates substrates involved in cytoskeletal organization where RIL is crucial, thereby enhancing RIL's role in stabilizing actin structures and cell adhesion. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Acts as an activator of protein kinase C (PKC), influencing cytoskeletal reorganization. PKC activation leads to changes in actin dynamics and cellular adhesion, where RIL is significant, thereby enhancing RIL's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A specific inhibitor of PI3K, altering cell migration and cytoskeletal rearrangement dynamics. This alteration potentially enhances RIL's function in these processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2 in the MAPK/ERK pathway, shifting signaling towards pathways involving RIL, particularly in cytoskeletal organization and cell adhesion, thus enhancing RIL's activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Selectively inhibits p38 MAP kinase, activating alternative signaling pathways that converge on cytoskeletal dynamics and cell adhesion, where RIL is involved, thereby enhancing RIL's activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A potent and selective inhibitor of PI3K, influencing pathways governing cytoskeletal organization and cell migration, thereby indirectly enhancing RIL's activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, affecting pathways related to cytoskeletal dynamics and cell adhesion, thus potentially enhancing RIL's role in these processes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
An ionophore that increases intracellular calcium levels, activating pathways involved in cytoskeletal rearrangement and cell adhesion, thereby potentially enhancing RIL's activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum protein kinase inhibitor. Its inhibition of specific kinases can enhance RIL's functionality in cytoskeletal dynamics. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
A tyrosine kinase inhibitor, modulating pathways intersecting with those involving RIL, especially in cytoskeletal organization and cell adhesion, thus enhancing RIL's activity. | ||||||